SS18-SSX Antibody / Protein SSXT, Clone: [SS18.SSX/12628R], Rabbit, Monoclonal

Artikelnummer: NSJ-V5838-20UG
Artikelname: SS18-SSX Antibody / Protein SSXT, Clone: [SS18.SSX/12628R], Rabbit, Monoclonal
Artikelnummer: NSJ-V5838-20UG
Hersteller Artikelnummer: V5838-20UG
Alternativnummer: NSJ-V5838-20UG
Hersteller: NSJ Bioreagents
Wirt: Rabbit
Kategorie: Antikörper
Applikation: IHC-P, WB
Spezies Reaktivität: Human
Immunogen: A recombinant fragment corresponding to the fusion site of human SS18-SSX protein was used as the immunogen for the SS18-SSX antibody.
S18 is a protein that has been shown to be a part of the SWI/SNF complex. The SS18-SSX fusion proteins are a result of in-frame fusions that fuse the SS18 gene on chromosome 18 with X chromosome genes SSX1, SSX2, and to a lesser extent SSX4. Human synovial sarcoma (SS) accounts for 8-10% of all soft tissue malignancies and 95% of these malignancies express the recurrent translocation of the SS18 gene on chromosome 18. The N-terminal SNH domain (SYT N-terminal homology domain) of the SS18 protein interacts with SWI/SNF chromatin remodeling complexes via the N terminal region of BRM and BRG1 subunits. Studies of the SS18-SSX fusion in SS suggest that endogenous SS18 competes with the mutant SS18-SSX fusion for occupancy in the SWI/SNF complexes resulting in the displacement of SNF5 (BAF47) subunit. Displacement of the SNF5 subunit results in altered function of the SWI/SNF complex that leads to deregulated expression of genes such as Sox2 in synovial sarcoma.
Klonalität: Monoclonal
Klon-Bezeichnung: [SS18.SSX/12628R]
UniProt: Q15532
Reinheit: Protein A affinity
Formulierung: 0.2 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced), 0.05% sodium azide
Antibody Type: Primary Antibody
Application Verdünnung: Immunohistochemistry (FFPE): 1-2ug/ml,Western blot: 2-4ug/ml
Anwendungsbeschreibung: Optimal dilution of the SS18-SSX antibody should be determined by the researcher.